Characterization of an allosteric inhibitor of fungal-specific C-24 sterol methyltransferase to treat Candida albicans infections
Characterization of an allosteric inhibitor of fungal-specific C-24 sterol methyltransferase to treat Candida albicans infections
复制标题
DOI:
10.1016/j.chembiol.2023.04.010
复制
发表时间:
2023-05-18
影响因子:
8.6
通讯作者:
Lou,Hongxiang
中科院分区:
文献类型:
--
作者:
Jin,Xueyang;Hou,Xuben;Lou,Hongxiang
Filamentation is an important virulence factor of the pathogenic fungusCandida albicans. The abolition ofCandida albicanshyphal formation by disrupting sterol synthesis is an important concept for the development of antifungal drugs with high safety. Here, we conduct a high-throughput screen using aC.albicansstrain expressing green fluorescent protein-labeled Dpp3 to identify anti-hypha agents by interfering with ergosterol synthesis. The antipyrine derivative H55 is characterized to have minimal cytotoxicity and potent inhibition ofC.albicanshyphal formation in multiple cultural conditions. H55 monotherapy exhibits therapeutic efficacy in mouse models of azole-resistant candidiasis. H55 treatment increases the accumulation of zymosterol, the substrate of C-24 sterol methyltransferase (Erg6). The results of enzyme assays, photoaffinity labeling, molecular simulation, mutagenesis, and cellular thermal shift assays support H55 as an allosteric inhibitor of Erg6. Collectively, H55, an inhibitor of the fungal-specific enzyme Erg6, holds potential to treatC.albicansinfections.